Lakefront Biotherapeutics NV (LKFT) — Tangible Net Worth Ratio
Lakefront Biotherapeutics NV (LKFT) has a Tangible Net Worth Ratio of 77.0% as of June 2026. This metric is calculated by deducting intangible assets ($750.35 Million) from net assets ($3.26 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Lakefront Biotherapeutics NV (LKFT) net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Lakefront Biotherapeutics NV Tangible Net Worth Ratio (2022–2025)
This chart shows how Lakefront Biotherapeutics NV's Tangible Net Worth Ratio has changed across 4 annual periods from 2022 to 2025. As of June 2026, the ratio stands at 77.0%, reflecting net assets of $3.26 Billion with intangible assets of $750.35 Million USD. Check asset allocation strategy of Lakefront Biotherapeutics NV to assess the company's strategic physical and investment asset allocation.
Annual Tangible Net Worth Ratio for Lakefront Biotherapeutics NV (2022–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Lakefront Biotherapeutics NV from 2022 to 2025, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Lakefront Biotherapeutics NV market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $3.24 Billion | $848.00K | $3.41 Billion | ▲ +5.7 pp |
| 2024 | 94.3% | $2.90 Billion | $164.86 Million | $4.14 Billion | ▼ -1.1 pp |
| 2023 | 95.4% | $2.80 Billion | $127.91 Million | $4.36 Billion | ▲ +1.2 pp |
| 2022 | 94.2% | $2.53 Billion | $146.35 Million | $4.73 Billion | — |